Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. (Record no. 11472756)

MARC details
000 -LEADER
fixed length control field 01681 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514010712.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200109s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/1097-0142(20010815)92:4<814::aid-cncr1387>3.0.co;2-8
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Recchia, F
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20010920
245 00 - TITLE STATEMENT
Title Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Aug 2001
300 ## - PHYSICAL DESCRIPTION
Extent 814-21 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Squamous Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Head and Neck Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ifosfamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isotretinoin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lalli, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lombardo, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Filippis, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saggio, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fabbri, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rosselli, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Capomolla, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rea, S
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 92
-- no. 4
-- p. 814-21
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/1097-0142(20010815)92:4<814::aid-cncr1387>3.0.co;2-8">https://doi.org/10.1002/1097-0142(20010815)92:4<814::aid-cncr1387>3.0.co;2-8</a>
Public note Available from publisher's website

No items available.